Waltz to Serve on NIH Study Section
Susan Waltz, PhD, professor of cancer biology and member of both the Cincinnati Cancer Center and the UC Cancer Institute, has been asked to serve on the Cancer Molecular Pathology Study Section for the National Institutes of Health, for the term beginning July 1, 2014 and ending June 30, 2020.
The Cancer Molecular Pathobiology [CAMP] Study Section reviews applications involving the pathology of the malignant cell with the emphasis on mechanisms controlling cell growth and death, and the molecular events in gene regulation.
Emphasis is on pathological approaches to oncogenesis and the basic cellular events involving growth of transformed cells in animal models, with more translational studies in human cells.
Tags
Related Stories
UC study shows lack of awareness for lung cancer screenings across country
August 21, 2026
University of Cincinnati Cancer Center researchers have published a study in the American Journal of Surgery that found only 15% of eligible American adults have discussed lung cancer screening with their doctors.This research emphasizes the need to spread awareness and better educate the public about screening through low-dose computed tomography.
UC radiation oncologist speaks with Local 12 news about clinical trial for head and neck cancer treatment
August 10, 2026
Dr. Sara Medek, a UC radiation oncology professor, speaks with Local 12 news about a new clinical trial aimed at reducing radiation in certain areas while still treating cancer effectively but with fewer painful side effects.
Cancer Center director charts future based on collaboration, AI
August 10, 2026
David Gius, MD, PhD, was featured in a Cincinnati Business Courier article and The Cancer Letter’s “The Directors" podcast discussing his priorities and goals as he recently took the helm as director of the University of Cincinnati Cancer Center.